top of page

Search Results

30 items found for "Ferring Pharmaceuticals"

  • Ep 90 with Dr. Nariman Balenga

    In 2021, I joined the Ferring Research Institute of Ferring Pharmaceuticals in San Diego as a scientist

  • Ep 127 with Dr. Evi Kostenis

    Evi Kostenis "Pharmacist by training - PhD in Pharmacology - Postdoc at the NIH with Dr. Pharmacology at 7TM Pharma in Denmark; Full professor, department chair and director of the institute for pharmaceutical

  • Ep 63 with Dr. Khaled Abdelrahman

    Khaled Abdelrahman graduated in 2006 with a BSc in Pharmaceutical Sciences from Alexandria University He is also a Registered Pharmacist in Canada and held two of the most prestigious Clinician Postdoctoral

  • A positive Allosteric Modulator of M1 Acetylcholine Receptors Improves Cognitive Deficits in Male and Female Alzheimer’s Mice

    Khaled Abdelrahman graduated in 2006 with a BSc in Pharmaceutical Sciences from Alexandria University He is also a Registered Pharmacist in Canada and held two of the most prestigious Clinician Postdoctoral

  • Structure-based discovery of functionally selective 5-HT1A receptor agonists

    He subsequently returned to Munich as a research associate at the Institute of Pharmaceutical Chemistry Habilitus, he was appointed at the University of Bonn as a Professor of Pharmaceutical Chemistry declining Peter has been chaired Full Professor of Pharmaceutical / Medicinal Chemistry at the Friedrich-Alexander University Erlangen-Nürnberg and declined an offer for the Chair for Pharmaceutical Chemistry at the

  • Ep 150 with Dr GPCR Team

    GPCR About John Azietaku John Teye Azietaku,PhD is a trained pharmacist, holding a Ph.D. in Drug Discovery committed to leveraging his expertise to enhance healthcare outcomes and contribute to the growth of the pharmaceutical GPCR About Cam Sinh Lu Cam Sinh Lu is a PhD student at Monash Institute of Pharmaceutical Sciences, Monash

  • GPCR Retreat 2023 - Part II

    Khaled Abdelrahman graduated in 2006 with a BSc in Pharmaceutical Sciences from Alexandria University He is also a Registered Pharmacist in Canada and held two of the most prestigious Clinician Postdoctoral

  • Ep 37 with Dr. Samuel Hoare

    data analyst and the founder of Pharmechanics LLC , a consultancy and data analysis company supporting pharmaceutical Hoare was a pharmacology leader in the pharmaceutical industry for 15 years at Neurocrine Biosciences

  • Advanced data analysis for GPCR pharmacology | Dr. GPCR Ecosystem

    He consults with numerous pharmaceutical, biotech, life science and academic organizations in understanding He worked as a pharmacology leader in the pharmaceutical industry for 15 years at Neurocrine Biosciences

  • Ep 81 with Dr. Christel Menet

    I then started my career at Evotec before moving to Domain Therapeutics (called Faust pharmaceutical

  • Ep 152 with Dr Arthur Christopoulos

    Christopoulos is the Professor of Analytical Pharmacology and the Dean of the Faculty of Pharmacy & Pharmaceutical In 2023, he was elected a Fellow of the Pharmaceutical Society of Australia. " Dr. Pharmaceutical Industry Experiences and GPCR History Arthur shared his experiences in the pharmaceutical

  • Ep 30 with Dr. Elva Zhao

    Elva Zhao About this episode Elva is currently a research fellow at the Monash Institute of Pharmaceutical

  • Ep 25 with Dr. Annette Gilchrist

    Gilchrist is also an associate professor at the Department of Pharmaceutical Sciences.

  • Ep 67 with Dr. Graham Ladds

    These investigations have enabled him to foster strong collaborations with the pharmaceutical industry

  • Ep 96 with R. Scott Struthers

    Struthers co-founded and serves as board chair at Radionetics Oncology, a pharmaceutical company focused

  • Ep 38 with Dr. Alexander S. Hauser

    He received the “HC Ørsted Research talent prize” and “Bayer Pharmaceuticals Ph.D.

  • Ep 88 with Dr. Hannes Schihada

    By the end of 2021, I moved back to Germany and joined the pharmaceutical chemistry group of Peter Kolb

  • Ep 148 with Dr Arthur Christopoulos

    Christopoulos is the Professor of Analytical Pharmacology and the Dean of the Faculty of Pharmacy & Pharmaceutical In 2023, he was elected a Fellow of the Pharmaceutical Society of Australia. " Dr. Lastly, they discussed the growth and development of the Monash Institute of Pharmaceutical Sciences, They also discussed the disruption within the pharmaceutical sector, the importance of workforce development

  • Ep 149 with Dr Arthur Christopoulos

    Christopoulos is the Professor of Analytical Pharmacology and the Dean of the Faculty of Pharmacy & Pharmaceutical In 2023, he was elected a Fellow of the Pharmaceutical Society of Australia. " Dr. Lastly, they discussed the growth and development of the Monash Institute of Pharmaceutical Sciences, They also discussed the disruption within the pharmaceutical sector, the importance of workforce development

  • Ep 35 with Dr. Brian Arey

    He then moved to work in the pharmaceutical industry where he has held positions of increasing responsibility

  • Ep 34 with Dr. Brian Arey

    He then moved to work in the pharmaceutical industry where he has held positions of increasing responsibility

  • Ep 33 with Dr. David E. Gloriam

    University of Copenhagen where he leads a research cluster for GPCR function and drug discovery and a Pharmaceutical

  • Ep 92 with Dr. Stephane Angers

    Angers established his independent research program in the Department of Pharmaceutical Sciences at the

  • Ep 95 with Chris Langmead

    and Better Medicines Theme Leader of the Neuromedicines Discovery Centre at the Monash Institute of Pharmaceutical

  • Ep 71 with Dr. Jean Martin Beaulieu

    of D2R signaling and explores the potential usefulness of beta-arrestins for the development of new pharmaceutical

  • Pancreatic ductal adenocarcinoma, β-blockers and antihistamines: A clinical trial is needed

    As a repurposing of generic drugs, this is not likely to be appealing to pharmaceutical companies and

  • Mechanistic exploration of bioactive constituents in Gnetum gnemon for GPCR-related cancer treatment through network pharmacology and molecular docking

    explored the capacity of bioactive compounds derived from Gnetum gnemon (GG) for the development of of pharmaceuticals

  • Interrogating Multiscale Receptors Functions in Space

    of D2R signaling and explores the potential usefulness of beta-arrestins for the development of new pharmaceutical

bottom of page